BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24752447)

  • 1. Soluble HLA-I/peptide monomers mediate antigen-specific CD8 T cell activation through passive peptide exchange with cell-bound HLA-I molecules.
    Allard M; Oger R; Benlalam H; Florenceau L; Echasserieau K; Bernardeau K; Labarrière N; Lang F; Gervois N
    J Immunol; 2014 Jun; 192(11):5090-7. PubMed ID: 24752447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
    Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
    Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.
    Puppo F; Contini P; Ghio M; Indiveri F
    ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of gammadelta T cell survival by soluble HLA-I: involvement of CD8 and activating killer Ig-like receptors.
    Poggi A; Contini P; Catellani S; Setti M; Murdaca G; Zocchi MR
    Eur J Immunol; 2005 Sep; 35(9):2670-8. PubMed ID: 16114098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency and mechanism of antigen-specific CD8+ T-cell activation using synthetic long peptides.
    Zandvliet ML; Kester MG; van Liempt E; de Ru AH; van Veelen PA; Griffioen M; Guchelaar HJ; Falkenburg JH; Meij P
    J Immunother; 2012; 35(2):142-53. PubMed ID: 22306902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes.
    Puppo F; Contini P; Ghio M; Brenci S; Scudeletti M; Filaci G; Ferrone S; Indiveri F
    Int Immunol; 2000 Feb; 12(2):195-203. PubMed ID: 10653855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
    Murdaca G; Contini P; Setti M; Cagnati P; Lantieri F; Indiveri F; Puppo F
    Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimerization of soluble HLA-G by IgG-Fc fragment augments ILT2-mediated inhibition of T-cell alloresponse.
    Zhong M; Weng X; Liang Z; Lu S; Li J; Chen X; Li Q; Sun W; Song Y; Shen G; Wu X
    Transplantation; 2009 Jan; 87(1):8-15. PubMed ID: 19136885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.
    Joosten SA; van Meijgaarden KE; van Weeren PC; Kazi F; Geluk A; Savage ND; Drijfhout JW; Flower DR; Hanekom WA; Klein MR; Ottenhoff TH
    PLoS Pathog; 2010 Feb; 6(2):e1000782. PubMed ID: 20195504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble plasma HLA peptidome as a potential source for cancer biomarkers.
    Bassani-Sternberg M; Barnea E; Beer I; Avivi I; Katz T; Admon A
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18769-76. PubMed ID: 20974924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro refolding and functional study of soluble HLA-G1-peptide complex].
    Yang JN; Wu XW; Liang ZH; Han JY; Huang YF; Gong FL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):265-8. PubMed ID: 15862135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells.
    Rizzo R; Campioni D; Stignani M; Melchiorri L; Bagnara GP; Bonsi L; Alviano F; Lanzoni G; Moretti S; Cuneo A; Lanza F; Baricordi OR
    Cytotherapy; 2008; 10(4):364-75. PubMed ID: 18574769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an HLA-DQ6-derived peptide recognized by mouse MHC class I H-2Db-restricted CD8+ T cells in HLA-DQ6 transgenic mice.
    Takeshita T; Fukui Y; Yamamoto K; Yamane K; Inamitsu T; Kamikawaji N; Sasazuki T
    Jpn J Hum Genet; 1997 Mar; 42(1):225-32. PubMed ID: 9184003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients.
    Scheibenbogen C; Lee KH; Mayer S; Stevanovic S; Moebius U; Herr W; Rammensee HG; Keilholz U
    Clin Cancer Res; 1997 Feb; 3(2):221-6. PubMed ID: 9815676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. sHLA-I contaminating molecules as novel mechanism of ex vivo/in vitro transcriptional and posttranscriptional modulation of transforming growth factor-beta in CD8+ T lymphocytes and neutrophils after intravenous immunoglobulin treatment.
    Ghio M; Contini P; Negrini S; Proietti M; Gonella R; Ubezio G; Ottonello L; Indiveri F
    Transfusion; 2010 Mar; 50(3):547-55. PubMed ID: 19906035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects of blood transfusions: the synergic role of soluble HLA Class I free heavy-chain molecules detectable in blood components.
    Ghio M; Contini P; Ubezio G; Mazzei C; Puppo F; Indiveri F
    Transfusion; 2008 Aug; 48(8):1591-7. PubMed ID: 18466172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of CD8-MHC class I interaction in detection and sorting efficiencies of antigen-specific T cells using MHC class I/peptide multimers: contribution of pMHC valency.
    Neveu B; Echasserieau K; Hill T; Kuus-Reichel K; Houssaint E; Bonneville M; Saulquin X
    Int Immunol; 2006 Jul; 18(7):1139-45. PubMed ID: 16751231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.